Frontlight ResearchEarly access
CompletedNo phase
Competitive Revision for CLARO: Collaboration Leading to Addiction Treatment and Recovery From Other Stresses
Key facts
- Who runs it
- RAND
- Where
- Albuquerque, Belen, Edgewood, Los Angeles, Los Lunas, and Santa Monica, United StatesSee the 12 sites
- Trial code
- Status
- Completed
- People taking part
- 68 people enrolled
- Started
- 31 Aug 2022
- Ended
- 12 Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Collaborative care Plus
- Record updated
- 9 August 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- 18 and older
- Receiving primary care at one of the participating clinical sites
- Has OUD and one or more specific co-occurring behavioral health disorders (depression and PTSD)
Who cannot take part
- Receiving both MOUD and psychotropic medication from a provider outside of the primary care health system at which the patient is enrolled
- Not receiving primary care at one of the participating clinical sites
- Under 18
- Does not speak English or Spanish
- Unable to consent
Where in United States
- First Choice - Alameda Medical CenterAlbuquerque, United States
- First Choice Community Healthcare - Alamosa Medical CenterAlbuquerque, United States
- First Choice Community Healthcare - North Valley Medical CenterAlbuquerque, United States
- First Choice Community Healthcare - South Broadway Medical CenterAlbuquerque, United States
- First Choice Community Healthcare - South Valley Medical/Dental CenterAlbuquerque, United States
- University of New Mexico Family Health Clinic, North ValleyAlbuquerque, United States
- University of New Mexico Family Health Clinic, Southeast HeightsAlbuquerque, United States
- First Choice Community Healthcare - Belen Medical CenterBelen, United States
- First Choice Community Healthcare - Edgewood Medical/Dental CenterEdgewood, United States
- Hubert Humphrey Comprehensive Health CenterLos Angeles, United States
- First Choice Community Healthcare - Los Lunas Medical/Dental CenterLos Lunas, United States
- Providence Saint John's Health CenterSanta Monica, United States
About the trial
What the trial wants to find out
The purpose of this study is to develop and then test an enhanced version of the parent study's collaborative care intervention for co-occurring disorders (CC-COD) to reduce the risk of suicide and overdose among individuals with opioid use disorder (OUD) in combination with PTSD/depression. The parent study is CLARO, Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (NCT04559893).
The 2 groups in the trial
- Collaborative Care PlusTreatment being tested
Intervention is administered to patients in this arm. Care to be delivered via collaborative care. The supplement intervention adds family involvement in care and Caring Contacts, a suicide prevention method.
- ControlNo study treatment, for comparison
Patients in this arm will receive enhanced usual care.
Results explained
A paper that names this trial, explained in plain words.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Competitive Revision for Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness
- Publications
- Collaborative Care for Opioid Use Disorder and Mental Illness: The CLARO Randomized Clinical Trial.JAMA internal medicine, 2026
- Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO): process of adapting collaborative care for co-occurring opioid use and mental disorders.Addiction science & clinical practice, 2022
- Record updated
- 9 August 2024